Autologous BM-MSC

DRUG3 trials

Sponsors

Fundacion De Investigacion Biomedica De Salamanca, Fondazione Policlinico Universitario Campus Bio-Medico

Conditions

Chronic Low-back PainIntervertebral Disc DegenerationKnee osteoarthritis

Phase 2

Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD

CompletedNCT04759105

Fondazione Policlinico Universitario Campus Bio-MedicoChronic Low-back Pain, Intervertebral Disc Degeneration

Start: 2019-11-03End: 2023-11-27Updated: 2025-05-25

Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD

RecruitingNCT05066334

Fondazione Policlinico Universitario Campus Bio-MedicoChronic Low-back Pain, Intervertebral Disc Degeneration

Start: 2021-03-22End: 2025-10-31Target: 52Updated: 2025-05-25

Phase 3

Phase III, multicentre, randomized, open clinical trial comparing treatment with allogenic mesenchymal cells against autologous mesenchymal cells and against active control with hyaluronic acid in patients with knee osteoarthritis.

Active, not recruitingCTIS2024-514545-11-00

Fundacion De Investigacion Biomedica De SalamancaKnee osteoarthritis

Start: 2021-05-26Target: 120Updated: 2025-11-12